{"groups":[{"description":"All participants will receive a conditioning regimen of Fludarabine, Melphalan and Total Body Irradiation prior to transplantation of HLA-Haploidentical Related Hematopoietic Cells (Haplo-HCT)\n\nFludarabine: Fludarabine 30mg/m\\^2/day will be administered over 30-60 minutes intravenous infusion on Days -6 through -2 for a total dose of 150 mg/m\\^2\n\nMelphalan: Melphalan 70 mg/m\\^2 over 45 minutes will be administered Day -6. Melphalan dose will be calculated based on Actual Body Weight.\n\nTotal Body Irradiation: Total Body Irradiation (TBI) will be delivered at a dose of 200 centigray units (cGy)","id":"FG000","title":"Conditioning Regimen + Transplant"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"34"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"34"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}